Search Results Search Sort by RelevanceMost Recent State of the Art and Science Oct 2009 Secondary Management of Ischemic Stroke Derek Riebau, MD and Lisa Hermann, MD Virtual Mentor. 2009;11(10):772-777. doi: 10.1001/virtualmentor.2009.11.10.cprl1-0910. Health Law Aug 2004 Words Count as Much as Deeds Leah Eisenberg and Melissa Junge, MBA Virtual Mentor. 2004;6(8):353-356. doi: 10.1001/virtualmentor.2004.6.8.hlaw1-0408. Podcast Oct 2021 Author Interview: When Should Neuroendovascular Care for Patients With Acute Stroke Be Palliative? Drs Michael Young, Robert Regenhardt, and Leonard Sokol join Ethics Talk to discuss their article, coauthored with Dr Thabele Leslie-Mazwi: "When Should Neuroendovascular Care for Patients With Acute Stroke Be Palliative?" Case and Commentary Oct 2021 When Should Neuroendovascular Care for Patients With Acute Stroke Be Palliative? Michael J. Young, MD, MPhil, Robert W. Regenhardt, MD, PhD, Leonard L. Sokol, MD, and Thabele M. Leslie-Mazwi, MD For some patients whose survival is extended by disease-modifying interventions, little guidance about clinical and ethical complexities exist. AMA J Ethics. 2021;23(10):E783-793. doi: 10.1001/amajethics.2021.783.
State of the Art and Science Oct 2009 Secondary Management of Ischemic Stroke Derek Riebau, MD and Lisa Hermann, MD Virtual Mentor. 2009;11(10):772-777. doi: 10.1001/virtualmentor.2009.11.10.cprl1-0910.
Health Law Aug 2004 Words Count as Much as Deeds Leah Eisenberg and Melissa Junge, MBA Virtual Mentor. 2004;6(8):353-356. doi: 10.1001/virtualmentor.2004.6.8.hlaw1-0408.
Podcast Oct 2021 Author Interview: When Should Neuroendovascular Care for Patients With Acute Stroke Be Palliative? Drs Michael Young, Robert Regenhardt, and Leonard Sokol join Ethics Talk to discuss their article, coauthored with Dr Thabele Leslie-Mazwi: "When Should Neuroendovascular Care for Patients With Acute Stroke Be Palliative?"
Case and Commentary Oct 2021 When Should Neuroendovascular Care for Patients With Acute Stroke Be Palliative? Michael J. Young, MD, MPhil, Robert W. Regenhardt, MD, PhD, Leonard L. Sokol, MD, and Thabele M. Leslie-Mazwi, MD For some patients whose survival is extended by disease-modifying interventions, little guidance about clinical and ethical complexities exist. AMA J Ethics. 2021;23(10):E783-793. doi: 10.1001/amajethics.2021.783.